Innovate Biopharmaceuticals Inc. (INNT)

3.085 +0.845 (+37.723%)

IEX Real-Time Price

12:14:38 PM EST.

NASDAQ Capital Market : Healthcare

Prev Close 2.24

Price Open 2.24

Volume: 1.07M

Avg Volume: 300,113

Market Cap: 80.43M

P/E Ratio -

52 Wk Range 2.2-50.5



INNT Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
24.66M
1.66M
2.66
6.71%

2018-09-28
24.66M
1.69M
1.46
6.84%

2018-09-14
24.47M
1.53M
1.59
6.25%

2018-08-31
24.47M
1.21M
1.86
4.92%




INNT Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-15
Q2 2018
N/A
-0.20 (2)
-0.16
0.04

News

Microcaps dominate midday movers (2018-11-20 12:40 SeekingAlpha)

More news on: Sphere 3D Corp., NF Energy Saving Corp., Zedge, Inc., Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 26.07M

Top 15 Institution Percent: 12.80

Price To Sales: 102.39

Price To Book: 153.36

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -344.57

Return On Equity: 3798.33

Profit Margin: N/A

Price History

Beta: -5.73

50-day Moving Avg: 4.28

200-day Moving Avg: 11.50

YTD Change: -62.35

5-day Change: -13.85

1-month Change: -35.82

3-month Change: -64.27

6-month Change: -78.23

1-year Change: -63.28

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Innovate Biopharmaceuticals Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.innovatebiopharma.com

Innovate Biopharmaceuticals Inc is a clinical stage biotechnology company. The company is engaged in developing novel medicines for autoimmune/ inflammatory disease.